189 related articles for article (PubMed ID: 24760750)
21. [Liposomal daunorubicine combined with cytarabine in the treatment of relapsed/refractory acute myeloid leukemia in children].
Reinhardt D; Hempel G; Fleischhack G; Schulz A; Boos J; Creutzig U
Klin Padiatr; 2002; 214(4):188-94. PubMed ID: 12165900
[TBL] [Abstract][Full Text] [Related]
22. Health conditions and quality of life in survivors of childhood acute myeloid leukemia comparing post remission chemotherapy to BMT: a report from the children's oncology group.
Schultz KA; Chen L; Chen Z; Kawashima T; Oeffinger KC; Woods WG; Nicholson HS; Neglia JP
Pediatr Blood Cancer; 2014 Apr; 61(4):729-36. PubMed ID: 24285698
[TBL] [Abstract][Full Text] [Related]
23. Long-term health outcomes in survivors of childhood AML treated with allogeneic HSCT: a NOPHO-AML Study.
Wilhelmsson M; Glosli H; Ifversen M; Abrahamsson J; Winiarski J; Jahnukainen K; Hasle H;
Bone Marrow Transplant; 2019 May; 54(5):726-736. PubMed ID: 30242226
[TBL] [Abstract][Full Text] [Related]
24. Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group.
Tomizawa D; Tabuchi K; Kinoshita A; Hanada R; Kigasawa H; Tsukimoto I; Tsuchida M;
Pediatr Blood Cancer; 2007 Aug; 49(2):127-32. PubMed ID: 16807916
[TBL] [Abstract][Full Text] [Related]
25. [Prognosis of children with acute myelocytic leukemia after first relapse].
Creutzig U; Ritter J; Boos J; Zimmermann M; Bender-Götze C; Stahnke K
Klin Padiatr; 1998; 210(4):207-11. PubMed ID: 9743954
[TBL] [Abstract][Full Text] [Related]
26. Outcome in children with relapsed acute myeloid leukemia after initial treatment with the French Leucemie Aique Myeloide Enfant (LAME) 89/91 protocol of the French Society of Pediatric Hematology and Immunology.
Aladjidi N; Auvrignon A; Leblanc T; Perel Y; Bénard A; Bordigoni P; Gandemer V; Thuret I; Dalle JH; Piguet C; Pautard B; Baruchel A; Leverger G;
J Clin Oncol; 2003 Dec; 21(23):4377-85. PubMed ID: 14645428
[TBL] [Abstract][Full Text] [Related]
27. Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia.
Schmiegelow K; Forestier E; Hellebostad M; Heyman M; Kristinsson J; Söderhäll S; Taskinen M;
Leukemia; 2010 Feb; 24(2):345-54. PubMed ID: 20010622
[TBL] [Abstract][Full Text] [Related]
28. [Response rate of AML-XH-99 protocol in the treatment of 82 childhood acute myeloid leukemia].
Li J; Gu LJ; Xue HL; Tang JY; Chen J; Zhao HJ; Chen J; Pan C; Wang YP; Ye H
Zhonghua Xue Ye Xue Za Zhi; 2004 Jun; 25(6):351-4. PubMed ID: 15308014
[TBL] [Abstract][Full Text] [Related]
29. Improved treatment results for childhood acute myeloid leukemia in Taiwan.
Liang DC; Chan TT; Lin KH; Lin DT; Lu MY; Chen SH; Liu HC; Lin MT; Lee MT; Shu SG; Chang TK; Chen JS; Hsiao CC; Hung IJ; Hsieh YL; Chen RL; Cheng SN; Chang WH; Lee CH; Lin KS
Leukemia; 2006 Jan; 20(1):136-41. PubMed ID: 16281075
[TBL] [Abstract][Full Text] [Related]
30. Acute Myeloid Leukemia in Adolescents and Young Adults Treated in Pediatric and Adult Departments in the Nordic Countries.
Wennström L; Edslev PW; Abrahamsson J; Nørgaard JM; Fløisand Y; Forestier E; Gustafsson G; Heldrup J; Hovi L; Jahnukainen K; Jonsson OG; Lausen B; Palle J; Zeller B; Holmberg E; Juliusson G; Stockelberg D; Hasle H; ; ;
Pediatr Blood Cancer; 2016 Jan; 63(1):83-92. PubMed ID: 26281822
[TBL] [Abstract][Full Text] [Related]
31. Early cardiac outcomes following contemporary treatment for childhood acute myeloid leukemia: a North American perspective.
Orgel E; Zung L; Ji L; Finklestein J; Feusner J; Freyer DR
Pediatr Blood Cancer; 2013 Sep; 60(9):1528-33. PubMed ID: 23441080
[TBL] [Abstract][Full Text] [Related]
32. Cytogenetic abnormalities and monosomal karyotypes in children and adolescents with acute myeloid leukemia: correlations with clinical characteristics and outcome.
Manola KN; Panitsas F; Polychronopoulou S; Daraki A; Karakosta M; Stavropoulou C; Avgerinou G; Hatzipantelis E; Pantelias G; Sambani C; Pagoni M
Cancer Genet; 2013 Mar; 206(3):63-72. PubMed ID: 23411131
[TBL] [Abstract][Full Text] [Related]
33. Twenty years of follow-up among survivors of childhood and young adult acute myeloid leukemia: a report from the Childhood Cancer Survivor Study.
Mulrooney DA; Dover DC; Li S; Yasui Y; Ness KK; Mertens AC; Neglia JP; Sklar CA; Robison LL; Davies SM;
Cancer; 2008 May; 112(9):2071-9. PubMed ID: 18327823
[TBL] [Abstract][Full Text] [Related]
34. Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group.
Ravindranath Y; Yeager AM; Chang MN; Steuber CP; Krischer J; Graham-Pole J; Carroll A; Inoue S; Camitta B; Weinstein HJ
N Engl J Med; 1996 May; 334(22):1428-34. PubMed ID: 8618581
[TBL] [Abstract][Full Text] [Related]
35. Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese Childhood AML Cooperative Study Group.
Tsukimoto I; Tawa A; Horibe K; Tabuchi K; Kigasawa H; Tsuchida M; Yabe H; Nakayama H; Kudo K; Kobayashi R; Hamamoto K; Imaizumi M; Morimoto A; Tsuchiya S; Hanada R
J Clin Oncol; 2009 Aug; 27(24):4007-13. PubMed ID: 19620491
[TBL] [Abstract][Full Text] [Related]
36. Gastrointestinal and liver disease in Adult Life After Childhood Cancer in Scandinavia: A population-based cohort study.
Asdahl PH; Winther JF; Bonnesen TG; De Fine Licht S; Gudmundsdottir T; Holmqvist AS; Malila N; Tryggvadottir L; Wesenberg F; Dahlerup JF; Olsen JH; Hasle H;
Int J Cancer; 2016 Oct; 139(7):1501-11. PubMed ID: 27194488
[TBL] [Abstract][Full Text] [Related]
37. [IDA-FLAG (idarubicin, fludarabine, high dosage cytarabine and G-CSF)--an effective therapy regimen in treatment of recurrent acute myelocytic leukemia in children and adolescents. Initial results of a pilot study].
Fleischhack G; Graf N; Hasan C; Ackermann M; Breu H; Zernikow B; Bode U
Klin Padiatr; 1996; 208(4):229-35. PubMed ID: 8926688
[TBL] [Abstract][Full Text] [Related]
38. FLAG-liposomal doxorubicin (Myocet) regimen for refractory or relapsed acute leukemia pediatric patients.
Quarello P; Berger M; Rivetti E; Galletto C; Masetti R; Manicone R; Barisone E; Pession A; Fagioli F
J Pediatr Hematol Oncol; 2012 Apr; 34(3):208-16. PubMed ID: 22395219
[TBL] [Abstract][Full Text] [Related]
39. A population-based study of 272 children with acute myeloid leukaemia treated on two consecutive protocols with different intensity: best outcome in girls, infants, and children with Down's syndrome. Nordic Society of Paediatric Haematology and Oncology (NOPHO).
Lie SO; Jonmundsson G; Mellander L; Siimes MA; Yssing M; Gustafsson G
Br J Haematol; 1996 Jul; 94(1):82-8. PubMed ID: 8757513
[TBL] [Abstract][Full Text] [Related]
40. Residual disease monitoring in childhood acute myeloid leukemia by multiparameter flow cytometry: the MRD-AML-BFM Study Group.
; Langebrake C; Creutzig U; Dworzak M; Hrusak O; Mejstrikova E; Griesinger F; Zimmermann M; Reinhardt D
J Clin Oncol; 2006 Aug; 24(22):3686-92. PubMed ID: 16877738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
